Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04294667 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus (PHOENYCS GO) |
| First Submitted : | February 27, 2020 |
| First Submitted that Met QC Criteria : | March 2, 2020 |
| First Posted : | March 4, 2020 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |